Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Thomas Ollila"'
1
Akademický článek
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
Autor: Narendranath Epperla, Lei Feng, Nirav N. Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M. Stephens, Catherine J. Lee, Thomas Ollila, Geoffrey Shouse, Alexey V. Danilov, Kevin A. David, Pallawi Torka, Hamza Hashmi, Brian Hess, Stefan K. Barta, Jason T. Romancik, Jonathon B. Cohen, Kaitlin Annunzio, Adam S. Kittai, John Reneau, Joanna Zurko, Imran A. Nizamuddin, Jane N. Winter, Leo I. Gordon, Shuo Ma, Romil Patel, Loretta Nastoupil, Sairah Ahmed, Reem Karmali
Publikováno v: Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-7 (2023)
Abstract Chimeric antigen receptor T-cell therapy (CAR-T) has been successful in treating relapsed/refractory B-cell lymphomas. However, its role in the treatment of diseases involving the central nervous system (CNS) is not well studied. We performe
Externí odkaz: https://doaj.org/article/c3e2fa17ee934883ab1d81fbb67a6b3b
Zobrazit plný text záznamu
2
Analysis of Hematology and Oncology Fellowship Website Content and Diversity Representation
Autor: Arun Muthiah, Vanya Aggarwal, Chandrasekar Muthiah, Chapman Wei, Thomas Ollila, Matthew I. Quesenberry, Don S. Dizon
Publikováno v: JCO Oncology Practice. 18:e600-e609
PURPOSE: Hematology and oncology (HO) lags behind all medicine subspecialties in fellows under-represented in medicine (URM) despite a growing minority patient population. Websites have been effectively used in URM recruitment. We evaluated all US HO
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4eda829b1735ddc1084e6ccf1be05fa
https://doi.org/10.1200/op.21.00623
Zobrazit plný text záznamu
3
Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study
Autor: Thomas Ollila, James Butera, Pamela Egan, John Reagan, Anthony Thomas, Inna Yakirevich, Kelsey MacKinnon, Jeannine Margolis, Jessica McMahon, Valerie Rosati, Adam J Olszewski
Publikováno v: The oncologist. 27(7)
Background We conducted an investigator-initiated, phase I trial of vincristine sulfate liposomal injection (VSLI) in combination with bendamustine and rituximab (BR) for indolent B-cell (BCL) or mantle cell lymphoma. Methods Participants received 6
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edd848d45a457d0bfead5bc18748dee
https://pubmed.ncbi.nlm.nih.gov/35641232
Zobrazit plný text záznamu
6
CDKN2A Deletions Define an Unfavorable Subgroup within the MYD88/CD79B (MCD) Subtype of Diffuse Large B-Cell Lymphoma (DLBCL) and Are Mutually Exclusive with TP53 mutations
Autor: Thomas Ollila, Jo-Anne Vergilio, Chelsea Marcus, Adam J. Olszewski, Habibe Kurt, Radwa Sharaf, Lee A. Albacker
Publikováno v: Blood. 138:2392-2392
Background: Alterations (particularly biallelic deletions) of the tumor suppressor gene CDKN2A are frequent in the ultra-aggressive lymphoblastic (Quesnel et al, Blood 1995) and Burkitt lymphomas (Schmitz et al, Nature 2012). They also occur in DLBCL
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a4c4b1689527708e64f9975a7dc83776
https://doi.org/10.1182/blood-2021-146335
Zobrazit plný text záznamu
7
Abstract 172: Molecular predictors of central nervous system (CNS) recurrence in diffuse large B-cell lymphoma (DLBCL)
Autor: Adam J. Olszewski, Ashlee Sturtevant, Habibe Kurt, Jozal Waroich, Nimesh R. Patel, John Vatkevich, Thomas Ollila
Publikováno v: Cancer Research. 80:172-172
CNS recurrence is a devastating outcome after systemic treatment of DLBCL. Clinical features are poor at predicting CNS recurrence or guiding prophylactic therapy. However, emerging data suggest that specific mutational profiles in DLBCL may correlat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b619eb211a63a7c7b5ab2cd031ca68b2
https://doi.org/10.1158/1538-7445.am2020-172
Zobrazit plný text záznamu
8
Abstract 733: Clonotypic cell-free DNA(cfDNA) in the cerebrospinal fluid (CSF) of patients with aggressive lymphomas
Autor: Adam J. Olszewski, Anna Chorzalska, Diana O. Treaba, John L. Reagan, Andrew Hsu, Pamela C. Egan, Habibe Kurt, James Butera, William Rafelson, Thomas Ollila, Rabin Niroula, Jordan Robison, Chelsea D. Mullins, Patrycja M. Dubielecka
Publikováno v: Cancer Research. 80:733-733
Current methods for detection of CNS involvement in lymphoma (CSF cytology, flow cytometry) have very limited sensitivity, particularly in cases of parenchymal brain involvement. Early detection is however critical to institute CNS-directed therapy t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c44834ef0eb4d2ddf60f398d43ea6e2
https://doi.org/10.1158/1538-7445.am2020-733
Zobrazit plný text záznamu
9
Lymph node ratio, adjuvant chemotherapy and survival in resected non-small cell lung cancer and pN1 disease: A Brown University experience
Autor: Kalyan Mantripragada, Humera Khurshid, Thomas Ollila
Publikováno v: Journal of Clinical Oncology. 33:e18529-e18529
e18529 Background: Large retrospective analyses of the SEER database indicate that a higher lymph node ratio (LNR: The number of positive lymph nodes divided by the number of lymph nodes resected d...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f88c5e224c35619ece6179914d347cf
https://doi.org/10.1200/jco.2015.33.15_suppl.e18529
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje